• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-850
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 09/25/2022
Event Type  Injury  
Event Description
On september 26, 2022, senseonics was made aware of a false hypoglycemia incident where patient complained of inaccurate sensor readings.The incident happened on (b)(6) 2022 at around 3:00 pm.Patient reported that bg was 6.8 mmol/l where as sg reading was 4.2 mmol/l the eversense cgm system alerted low glucose even through bg was normal.User was not symptomatic and did not require any treatment.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of an internal review.The transmitter was not requested to be returned for evaluation as the preliminary analysis suggested the issue was temporary.The investigation analysis was based on the user's in vivo sensor data synced by the user on the data management system (dms), which is the data cloud platform for eversense systems.The reported fingerstick or the blood glucose (bg) value of 6.8 mmol/l around 3 pm cet on (b)(6) 2022, was not found in the dms, as it was likely not entered in the system.The reported sensor glucose (sg) reading of 4.2 mmol/l could not be confirmed as dms showed the sg value was 5.7 mmol/l at the time of event, which was within 20% of the fingerstick measurement (considered acceptable).The fingerstick measurements before and after the event displayed good agreement with the sensor readings.The overall system performance was reviewed, and it was performing within acceptable parameters.Currently, the sensor is in use and the system is displaying good agreement between the sensor readings and fingerstick measurements.No additional investigation was found necessary for this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key19009471
MDR Text Key338981148
Report Number3009862700-2024-00370
Device Sequence Number1
Product Code QCD
UDI-Device Identifier00817491023094
UDI-Public817491023094
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/28/2022
Device Model Number102208-850
Device Catalogue NumberFG-3400-50-001
Device Lot Number126886
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/09/2022
Initial Date FDA Received03/31/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/28/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-